文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

老年肝细胞癌患者肠道微生物组失调。

Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.

机构信息

Clinical Laboratory, Guangzhou Cadre Health Management Center, Guangzhou No. 11 People's Hospital, Guangzhou, China.

Clinical Laboratory, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

出版信息

Sci Rep. 2023 May 13;13(1):7797. doi: 10.1038/s41598-023-34765-w.


DOI:10.1038/s41598-023-34765-w
PMID:37179446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10182990/
Abstract

Fecal samples from participants aged 60-80 were collected and sequenced by a high-throughput second-generation sequencer to explore the structural composition of gut microbiota in elderly patients with hepatocellular carcinoma(HCC). Comparison of gut microbiota between patients with hepatocellular carcinoma and healthy controls, α diversity and β diversity were statistically different. At the genus level, compared with the normal group, the abundance of A Blautia, Fusicatenibacter, Anaerostipes, Lachnospiraceae_ND3007_group, CAG-56, Eggerthella, Lachnospiraceae_FCS020_group and Olsenella were decreased significantly in the LC group. In contrast, the abundance of Escherichia-Shigella, Fusobacterium, Megasphaera, Veillonella, Tyzzerella_4, Prevotella_2 and Cronobacter increased significantly. The KEGG and COG pathway analyses showed that the dysbiosis of gut bacteria in primary liver carcinoma is associated with several pathways, including amino acid metabolism, replication and repair, nucleotide metabolism, cell motility, cell growth and death, and transcription. Age is negatively associated with the abundance of Bifidobacterium. Lachnospiraceae_ ND3007_ group, [Eubacterium]hallii_group, Blautia, Fuscatenibacter and Anaerostipes are negatively correlated with ALT, AST and GGT levels (p < 0.05), respectively. Alpha-fetoprotein (AFP) is positively associated with the abundance of Erysipelatoclostridium, Magasphaera, Prevotella 2, Escherichia-Shigella, Streptococcus and [Eubacterium]eligens_group (p < 0.05), respectively. A random forest model showed that the genera Eggerthella, Anaerostipes, and Lachnospiraceae ND3007 group demonstrated the best predictive capacity. The area under the Receiver Operating Characteristic Curve of Eggerthella, Anaerostipes and Lachnospiraceae_ ND3007_ group are 0.791, 0.766 and 0.730, respectively. These data are derived from the first known gut microbiome study in elderly patients with hepatocellular carcinoma. Potentially, specific microbiota can be used as a characteristic index for screening, diagnosis, and prognosis of gut microbiota changes in elderly patients with hepatocellular carcinoma and even as a therapeutic clinical target.

摘要

从年龄在 60-80 岁的参与者中收集粪便样本,并使用高通量第二代测序仪对其进行测序,以探索老年肝细胞癌(HCC)患者肠道微生物组的结构组成。对 HCC 患者和健康对照组的肠道微生物组进行比较,α多样性和β多样性有统计学差异。在属水平上,与正常组相比,LC 组中 A Blautia、Fusicatenibacter、Anaerostipes、Lachnospiraceae_ND3007_group、CAG-56、Eggerthella、Lachnospiraceae_FCS020_group 和 Olsenella 的丰度显著降低。相反,Escherichia-Shigella、Fusobacterium、Megasphaera、Veillonella、Tyzzerella_4、Prevotella_2 和 Cronobacter 的丰度显著增加。KEGG 和 COG 途径分析表明,原发性肝癌肠道细菌的失调与多种途径有关,包括氨基酸代谢、复制和修复、核苷酸代谢、细胞运动、细胞生长和死亡以及转录。年龄与双歧杆菌的丰度呈负相关。Lachnospiraceae_ND3007_group、[Eubacterium]_hallii_group、Blautia、Fuscatenibacter 和 Anaerostipes 分别与 ALT、AST 和 GGT 水平呈负相关(p<0.05)。甲胎蛋白(AFP)与 Erysipelatoclostridium、Magasphaera、Prevotella 2、Escherichia-Shigella、Streptococcus 和 [Eubacterium]_eligens_group 的丰度呈正相关(p<0.05)。随机森林模型显示,Eggerthella、Anaerostipes 和 Lachnospiraceae_ND3007_group 这三个属具有最佳的预测能力。Eggerthella、Anaerostipes 和 Lachnospiraceae_ND3007_group 的受试者工作特征曲线下面积分别为 0.791、0.766 和 0.730。这些数据来源于对老年肝细胞癌患者进行的首次肠道微生物组研究。潜在地,特定的微生物群可以作为老年肝细胞癌患者肠道微生物组变化筛查、诊断和预后的特征指标,甚至可以作为治疗的临床靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/ff44b8036034/41598_2023_34765_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/ceb951c57a10/41598_2023_34765_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/6b767faa7f5b/41598_2023_34765_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/1bd9c5af0e20/41598_2023_34765_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/d7fcd0da8210/41598_2023_34765_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/138aaae0ebe5/41598_2023_34765_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/af98e81363d3/41598_2023_34765_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/f162e0b36973/41598_2023_34765_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/ff44b8036034/41598_2023_34765_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/ceb951c57a10/41598_2023_34765_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/6b767faa7f5b/41598_2023_34765_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/1bd9c5af0e20/41598_2023_34765_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/d7fcd0da8210/41598_2023_34765_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/138aaae0ebe5/41598_2023_34765_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/af98e81363d3/41598_2023_34765_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/f162e0b36973/41598_2023_34765_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85fb/10182990/ff44b8036034/41598_2023_34765_Fig8_HTML.jpg

相似文献

[1]
Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.

Sci Rep. 2023-5-13

[2]
Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.

Curr Oncol. 2023-2-2

[3]
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.

Appl Microbiol Biotechnol. 2024-12

[4]
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.

Hepatobiliary Pancreat Dis Int. 2017-8-15

[5]
Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.

J Viral Hepat. 2020-2

[6]
Identification of Dysfunctional Gut Microbiota Through Rectal Swab in Patients with Different Severity of Acute Pancreatitis.

Dig Dis Sci. 2020-11

[7]
Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.

Int J Biol Sci. 2019-9-7

[8]
and in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study.

Bioengineered. 2021-12

[9]
Alterations in the gut microbiota community are associated with childhood obesity and precocious puberty.

BMC Microbiol. 2024-8-24

[10]
Alterations in gut microbiota of esophageal squamous cell carcinoma patients.

J Gastroenterol Hepatol. 2022-10

引用本文的文献

[1]
Characterisation of the Faecal Microbiota in Dogs with Mast Cell Tumours Compared with Healthy Dogs.

Animals (Basel). 2025-7-27

[2]
Multi-omics analysis reveals gut microbiota-metabolite interactions and their association with liver function in autoimmune overlap syndrome.

World J Gastroenterol. 2025-7-7

[3]
Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma.

Front Pharmacol. 2025-5-19

[4]
The Gut Microbiome in Hepatocellular Carcinoma: Proliferation, Inhibition, Diagnosis, and Immunotherapy.

J Microbiol Biotechnol. 2025-5-15

[5]
Delites™ supplementation prevents metabolic syndrome onset and modulates gut microbiome in male Sprague Dawley rats fed on cholesterol- and fat-enriched diet: a randomized preclinical trial study.

Front Nutr. 2025-4-22

[6]
Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma.

World J Gastroenterol. 2025-4-21

[7]
Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts.

Gut Pathog. 2025-4-16

[8]
Biliary-intestinal anastomosis leads to alterations in intestinal flora and its flora metabolites and increases the risk of long-term postoperative complications: a case-control study.

Front Microbiol. 2025-2-26

[9]
Rumen microbiome associates with postpartum ketosis development in dairy cows: a prospective nested case-control study.

Microbiome. 2025-3-8

[10]
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma.

Gut Microbes. 2025-12

本文引用的文献

[1]
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review.

J Clin Med. 2023-2-24

[2]
The safety and prognosis of radical surgery in colorectal cancer patients over 80 years old.

BMC Surg. 2023-2-28

[3]
Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.

Curr Oncol. 2023-2-2

[4]
Intramedullary Spinal Cord Metastases from Breast Cancer: A Systematic Review.

Anticancer Res. 2023-2

[5]
Immunotherapy for older patients with cancer.

Curr Opin Support Palliat Care. 2023-3-1

[6]
Inhibition of in an infant simulator of the human intestinal microbial ecosystem using a potential synbiotic.

Front Microbiol. 2022-7-15

[7]
Ferulic acid improves intestinal barrier function through altering gut microbiota composition in high-fat diet-induced mice.

Eur J Nutr. 2022-10

[8]
promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota.

Aging (Albany NY). 2022-2-25

[9]
Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure.

Front Microbiol. 2022-1-31

[10]
Gut microbiome and health: mechanistic insights.

Gut. 2022-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索